487 related articles for article (PubMed ID: 31063743)
1. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
Zieba J; Sinclair D; Sebree T; Bonn-Miller M; Gutterman D; Siegel S; Karl T
Pharmacol Biochem Behav; 2019 Jun; 181():93-100. PubMed ID: 31063743
[TBL] [Abstract][Full Text] [Related]
2. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
Bilousova TV; Dansie L; Ngo M; Aye J; Charles JR; Ethell DW; Ethell IM
J Med Genet; 2009 Feb; 46(2):94-102. PubMed ID: 18835858
[TBL] [Abstract][Full Text] [Related]
3. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
[TBL] [Abstract][Full Text] [Related]
4. Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments.
Baker KB; Wray SP; Ritter R; Mason S; Lanthorn TH; Savelieva KV
Genes Brain Behav; 2010 Aug; 9(6):562-74. PubMed ID: 20398059
[TBL] [Abstract][Full Text] [Related]
5. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
Qin M; Zeidler Z; Moulton K; Krych L; Xia Z; Smith CB
Behav Brain Res; 2015 Sep; 291():164-171. PubMed ID: 25979787
[TBL] [Abstract][Full Text] [Related]
7. Normal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory Task.
Leach PT; Hayes J; Pride M; Silverman JL; Crawley JN
eNeuro; 2016; 3(1):. PubMed ID: 27022628
[TBL] [Abstract][Full Text] [Related]
8. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
[TBL] [Abstract][Full Text] [Related]
10. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
Brennan FX; Albeck DS; Paylor R
Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
[TBL] [Abstract][Full Text] [Related]
11. Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome.
King MK; Jope RS
Genes Brain Behav; 2013 Oct; 12(7):723-31. PubMed ID: 23941202
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome.
Rosenheck M; Sheeler C; Saré RM; Gurney ME; Smith CB
Neurobiol Dis; 2021 Nov; 159():105485. PubMed ID: 34411704
[TBL] [Abstract][Full Text] [Related]
13. FMRP Expression Levels in Mouse Central Nervous System Neurons Determine Behavioral Phenotype.
Arsenault J; Gholizadeh S; Niibori Y; Pacey LK; Halder SK; Koxhioni E; Konno A; Hirai H; Hampson DR
Hum Gene Ther; 2016 Dec; 27(12):982-996. PubMed ID: 27604541
[TBL] [Abstract][Full Text] [Related]
14. Behavioral Phenotype of Fmr1 Knock-Out Mice during Active Phase in an Altered Light/Dark Cycle.
Saré RM; Levine M; Smith CB
eNeuro; 2016; 3(2):. PubMed ID: 27294193
[TBL] [Abstract][Full Text] [Related]
15. Hyperactivity and lack of social discrimination in the adolescent Fmr1 knockout mouse.
Sørensen EM; Bertelsen F; Weikop P; Skovborg MM; Banke T; Drasbek KR; Scheel-Krüger J
Behav Pharmacol; 2015 Dec; 26(8 Spec No):733-40. PubMed ID: 26110222
[TBL] [Abstract][Full Text] [Related]
16. Brief report: altered social behavior in isolation-reared Fmr1 knockout mice.
Heitzer AM; Roth AK; Nawrocki L; Wrenn CC; Valdovinos MG
J Autism Dev Disord; 2013 Jun; 43(6):1452-8. PubMed ID: 23015112
[TBL] [Abstract][Full Text] [Related]
17. Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.
Liu ZH; Chuang DM; Smith CB
Int J Neuropsychopharmacol; 2011 Jun; 14(5):618-30. PubMed ID: 20497624
[TBL] [Abstract][Full Text] [Related]
18. Deletion of
Nolan SO; Reynolds CD; Smith GD; Holley AJ; Escobar B; Chandler MA; Volquardsen M; Jefferson T; Pandian A; Smith T; Huebschman J; Lugo JN
Brain Behav; 2017 Oct; 7(10):e00800. PubMed ID: 29075560
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors.
Manduca A; Buzzelli V; Rava A; Feo A; Carbone E; Schiavi S; Peruzzi B; D'Oria V; Pezzullo M; Pasquadibisceglie A; Polticelli F; Micale V; Kuchar M; Trezza V
Pharmacol Res; 2024 May; 203():107176. PubMed ID: 38583687
[TBL] [Abstract][Full Text] [Related]
20. GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the
Sinclair D; Featherstone R; Naschek M; Nam J; Du A; Wright S; Pance K; Melnychenko O; Weger R; Akuzawa S; Matsumoto M; Siegel SJ
eNeuro; 2017; 4(1):. PubMed ID: 28451631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
